Invalid! The Supreme Court Questions the Basis for Diagnostic Patents
This article was originally published in Start Up
Executive Summary
The Supreme Court has decided to hear a case--LabCorp. vs Metabolite--that could invalidate patents based on the correlation between natural biological markers, like proteins or genes, and a disease. The case strikes at the heart of the new diagnostics start-ups-and could also invalidate a host of pharmaceutical IP strategies.